INT227663

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.63
First Reported 2003
Last Reported 2009
Negated 0
Speculated 0
Reported most in Body
Documents 14
Total Number 14
Disease Relevance 7.64
Pain Relevance 1.85

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

lysosome (IDS)
Anatomy Link Frequency
muscle 2
IDS (Homo sapiens)
Pain Link Frequency Relevance Heat
imagery 213 95.68 Very High Very High Very High
Angina 430 93.20 High High
depression 10 80.04 Quite High
Inflammation 6 27.20 Quite Low
adenocard 30 26.00 Quite Low
cytokine 3 21.76 Low Low
tolerance 30 5.00 Very Low Very Low Very Low
Pain 20 5.00 Very Low Very Low Very Low
abdominal pain 10 5.00 Very Low Very Low Very Low
agonist 10 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Cardiovascular Disease 90 99.74 Very High Very High Very High
Infarction 120 98.04 Very High Very High Very High
Cv Unclassified Under Development 150 96.40 Very High Very High Very High
Coronary Artery Disease 451 93.60 High High
Syndrome 60 93.60 High High
Angina 280 93.20 High High
Coronary Heart Disease 40 92.72 High High
Stress 350 91.48 High High
Injury 6 91.24 High High
Acute Coronary Syndrome 150 90.04 High High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
The drugs were classified according to the ATC system and utilization of IDs was measured in DDD/100 bed-days and of IVFs in L/100 bed-days.
Localization (utilization) of IDs
1) Confidence 0.63 Published 2009 Journal McGill Journal of Medicine : MJM Section Body Doc Link PMC2687907 Disease Relevance 0 Pain Relevance 0
MPS, Regular user of MPS; non-MPS, occasional user of MPS. [252]
Localization (user) of MPS
2) Confidence 0.41 Published 2003 Journal Eur J Nucl Med Mol Imaging Section Body Doc Link PMC2562441 Disease Relevance 0.93 Pain Relevance 0.39
Diagnostic accuracy of MPS
Localization (accuracy) of MPS
3) Confidence 0.41 Published 2003 Journal Eur J Nucl Med Mol Imaging Section Body Doc Link PMC2562441 Disease Relevance 0.54 Pain Relevance 0.05
If there is a perception of underutilisation of MPS in the UK, how should correct usage be judged?
Localization (underutilisation) of MPS
4) Confidence 0.41 Published 2003 Journal Eur J Nucl Med Mol Imaging Section Body Doc Link PMC2562441 Disease Relevance 0 Pain Relevance 0
The current utilisation of MPS is reviewed and targets for service improvements are proposed.


Localization (utilisation) of MPS
5) Confidence 0.41 Published 2003 Journal Eur J Nucl Med Mol Imaging Section Body Doc Link PMC2562441 Disease Relevance 0.48 Pain Relevance 0.13
In the UK, the NSF states that MPS is indicated in patients with a high likelihood of a false positive exercise ECG, and an abnormal resting ECG is probably included in this statement [220].
Localization (indicated) of MPS associated with cardiovascular disease
6) Confidence 0.41 Published 2003 Journal Eur J Nucl Med Mol Imaging Section Body Doc Link PMC2562441 Disease Relevance 1.08 Pain Relevance 0.04
MPS, Regular user of MPS; non-MPS, occasional user of MPS. [252]
Localization (user) of MPS
7) Confidence 0.41 Published 2003 Journal Eur J Nucl Med Mol Imaging Section Body Doc Link PMC2562441 Disease Relevance 0.93 Pain Relevance 0.39
MPS, Regular user of MPS; non-MPS, occasional user of MPS. [252]
Localization (user) of MPS
8) Confidence 0.41 Published 2003 Journal Eur J Nucl Med Mol Imaging Section Body Doc Link PMC2562441 Disease Relevance 0.94 Pain Relevance 0.39
MPS, Regular user of MPS; non-MPS, occasional user of MPS. [252]
Localization (user) of MPS
9) Confidence 0.41 Published 2003 Journal Eur J Nucl Med Mol Imaging Section Body Doc Link PMC2562441 Disease Relevance 0.94 Pain Relevance 0.39
The highest quality score is 3, when the study involves a clearly defined population, when it avoids verification bias and when MPS is interpreted independently of angiography.
Localization (interpreted) of MPS
10) Confidence 0.41 Published 2003 Journal Eur J Nucl Med Mol Imaging Section Body Doc Link PMC2562441 Disease Relevance 0.54 Pain Relevance 0.04
Travin and colleagues used MPS in 134 patients within 14 days of uncomplicated infarction and showed that the extent of ischaemia was the only significant predictor of future cardiac events on Cox regression analysis (Fig. 4) [248].
Localization (used) of MPS associated with cv unclassified under development and infarction
11) Confidence 0.38 Published 2003 Journal Eur J Nucl Med Mol Imaging Section Body Doc Link PMC2562441 Disease Relevance 0.87 Pain Relevance 0.03
The rate of MPS in relation to muscle RNA concentration, a measure of the translational efficiency in muscle, was not different between men and women during basal, postabsorptive conditions (0.012±0.003 vs. 0.013±0.002 mg protein·µg RNA?
Localization (relation) of MPS in muscle
12) Confidence 0.07 Published 2008 Journal PLoS ONE Section Body Doc Link PMC2267222 Disease Relevance 0.05 Pain Relevance 0
Testosterone is well known to be anabolic and increases the basal rate of MPS in both healthy and hypogonadal young men [15], [16], [41].
Localization (rate) of MPS
13) Confidence 0.07 Published 2008 Journal PLoS ONE Section Body Doc Link PMC2267222 Disease Relevance 0.15 Pain Relevance 0
We, therefore, measured the fractional rate of MPS during basal, postabsorptive conditions and during feeding by using stable-isotope labeled amino acid tracer techniques in 65–80 year old men and women; we also measured the concentrations of total muscle RNA and protein to gain insight into the protein synthetic capacity and translational efficiency of the muscle [23], [24].
Localization (rate) of MPS in muscle
14) Confidence 0.07 Published 2008 Journal PLoS ONE Section Body Doc Link PMC2267222 Disease Relevance 0.18 Pain Relevance 0

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox